🇺🇸 FDA

Intelligence · Clinical Pipeline

Oncology · Phase III

Oncology programs at Phase III — ClinicalTrials.gov pipeline intelligence.

Programs
1,266

Quick answer

Oncology Phase III programs: NovaPharmaNews indexes 1,266 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Page 25 of 27

  1. [68Ga]Ga-PentixaFor, FLUDEOXYGLUCOSE (18F)

    Alphapharm Pty Ltd

    Marginal Zone Lymphoma

    phase 3 small molecule active

    1 trial

  2. a patient self-reporting applet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cancer Pain

    phase 3 other active

    1 trial

  3. adoptive immunotherapy

    Chinese PLA General Hospital

    Hepatocellular Carcinoma

    phase 3 mab completed

    1 trial

  4. aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)

    Regeneron UK Limited

    Ovarian Neoplasms

    phase 3 small molecule completed

    2 trials

  5. asparaginase

    Children's Hospital of Fudan University

    Leukemia

    phase 3 small molecule completed

    2 trials

  6. asparaginase

    United Therapeutics Europe Ltd

    Lymphoma

    phase 3 small molecule active

    1 trial

  7. bempegaldesleukin

    Nektar Therapeutics UK Limited

    Renal Cell Carcinoma

    phase 3 mab terminated

    1 trial

  8. bendamustine

    Teva Pharma GmbH

    Non-Hodgkin's Lymphoma

    phase 3 small molecule completed

    2 trials

  9. bexarotene

    Eisai Co.,

    Non-small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  10. brentuximab vedotin

    Takeda

    Hodgkin Lymphoma

    phase 3 small molecule completed

    3 trials

  11. brigatinib

    Takeda

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    2 trials

  12. camizestrant, Arimidex® 1 mg Filmtabletten, IBRANCE 75 mg hard capsules, Placebo to match camizestrant, Placebo to match Arimidex, LEUPRORELIN ACETATE, IBRANCE 125 mg hard capsules, IBRANCE 75 mg film-coated tablets, IBRANCE 100 mg hard capsules, IBRANCE 75 mg hard capsules, IBRANCE 100 mg hard capsules, IBRANCE 125 mg film-coated tablets, IBRANCE 100 mg film-coated tablets, IBRANCE 125 mg hard capsules, IBRANCE 100 mg hard capsules, Camizestrant, IBRANCE 125 mg hard capsules, IBRANCE 75 mg hard capsules, G

    AstraZeneca AB

    Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

    phase 3 small molecule active

    1 trial

  13. canakinumab

    Novartis Pharmaceuticals

    Non-small Cell Lung Cancer

    phase 3 small molecule terminated

    2 trials

  14. cemiplimab

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    3 trials

  15. cetuximab + cisplatin + vinorelbine

    Merck KGaA, Darmstadt, Germany

    Non Small Cell Lung Cancer (NSCLC)

    phase 3 small molecule completed

    1 trial

  16. chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Limited Stage Small Cell Lung Cancer

    phase 3 other active

    1 trial

  17. cisplatin

    Pari Pharma GmbH

    Lung Cancer

    phase 3 small molecule completed

    1 trial

  18. cisplatin

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 3 small molecule completed

    1 trial

  19. cisplatin i.p.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Carcinoma, Ovarian

    phase 3 small molecule active

    1 trial

  20. custirsen sodium

    Teva Pharma GmbH

    Castrate-Resistant Prostate Cancer

    phase 3 small molecule terminated

    1 trial

  21. cyclophosphamide

    Partner Therapeutics Limited

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  22. cyclosporine

    Takeda

    Leukemia

    phase 3 small molecule terminated

    1 trial

  23. dactinomycin

    Solid Biosciences

    Sarcoma

    phase 3 mab active

    1 trial

  24. dactinomycin

    Children's Hospital of Fudan University

    Kidney Cancer

    phase 3 mab completed

    1 trial

  25. daraxonrasib

    Revolution Medicines

    NSCLC (Non-small Cell Lung Cancer)

    phase 3 small molecule active

    1 trial

  26. daraxonrasib

    Revolution Medicines

    Pancreatic Cancer

    phase 3 small molecule active

    2 trials

  27. decitabine

    The First People's Hospital of Lianyungang

    Acute Myelocytic Leukemia

    phase 3 small molecule active

    1 trial

  28. desiccated thyroid extract (DTE)+levothyroxine (L-T4)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intermediate-to-High Risk Differentiated Thyroid Cancer

    phase 3 small molecule active

    1 trial

  29. doxorubicin hydrochloride

    United Therapeutics Europe Ltd

    Stage III Bladder Cancer

    phase 3 small molecule completed

    1 trial

  30. doxorubicin hydrochloride

    Children's Hospital of Fudan University

    Adult Alveolar Soft-part Sarcoma

    phase 3 small molecule completed

    1 trial

  31. doxorubicin in combination with palifosfamide-tris

    Alaunos Therapeutics

    Soft Tissue Sarcoma

    phase 3 small molecule completed

    1 trial

  32. educational internet site on prostate cancer screening

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 3 other completed

    1 trial

  33. elritercept, Placebo to match ker-050 solution for injection

    Takeda

    myelodysplastic neoplasms/syndromes (MDS)

    phase 3 small molecule active

    1 trial

  34. enfortumab vedotin, VINFLUNINE , DOCETAXEL , PACLITAXEL

    Astellas Pharma GmbH

    Locally advanced or metastatic urothelial cancer

    phase 3 small molecule active

    1 trial

  35. erlotinib

    Hoffmann-La Roche

    Non-Squamous Non-Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  36. esophagectomy

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 3 other active

    1 trial

  37. evorpacept, Herceptin 150 mg powder for concentrate for solution for infusion, Cyramza 10 mg/ml concentrate for solution for infusion, Paclitaxel 6 mg/mL concentrate for solution for infusion, Normal Saline (Sodium Chloride)

    Wuhan Createrna Science and Technology Co., Ltd

    Patients with HER2-overexpressing advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma that has progressed on or after a prior HER2-directed agent and fluoropyrimidine- or platinum-containing chemotherapy (2nd-line or 3rd-line)

    phase 3 small molecule active

    1 trial

  38. exemestane

    Partner Therapeutics Limited

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  39. favezelimab/pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Colorectal Cancer

    phase 3 mab completed

    1 trial

  40. fianlimab

    Regeneron UK Limited

    Advanced Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  41. fianlimab

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  42. filgrastim

    Solid Biosciences

    Lung Cancer

    phase 3 mab active

    1 trial

  43. filgrastim

    Hospital Authority, Hong Kong

    Brain and Central Nervous System Tumors

    phase 3 mab completed

    2 trials

  44. filgrastim

    Solid Biosciences

    Ovarian Cancer

    phase 3 mab completed

    1 trial

  45. filgrastim

    Solid Biosciences

    Lymphoma

    phase 3 mab active

    2 trials

  46. folic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Neoplasms

    phase 3 small molecule active

    1 trial

  47. furmonertinib 240 mg oral, daily

    ArriVent BioPharma

    Metastatic Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  48. gemcitabine

    NORTHWEST BIOTHERAPEUTICS INC

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

How many oncology Phase III programs exist?

1,266 programs match both the therapeutic area and stage filters in our published index.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.